Silatronix® awarded $10.1 million Navy ONR contract

MADISON, Wis.–(BUSINESS WIRE)–Silatronix® has been awarded a $10.1 million contract from the U.S. Navy Office of Naval Research (ONR). The contract, entitled “Organosilicon Electrolytes for Safe, High Energy, High-Nickel NMC Li-ion Batteries” will focus on the use of Organosilicon (OS) electrolytes to improve the cycling stability of Li-ion cells using NMC622 and NMC811 cathode materials in combination with various state-of-the-art anode materials. This ONR project leverages Silatronix® substantial expertise in the development of new OS based solvents for Li-ion battery applications, and the Company’s world class, Li-ion battery materials evaluation laboratory and analysis capability.

read more

$15-million DOE/NNSA award for medical isotope

JANESVILLE, Wis., Aug. 9, 2019 – SHINE Medical Technologies LLC today announced it has received a $15-million award from the Department of Energy’s National Nuclear Security Administration (DOE/NNSA). The award was made by the agency as part of its effort to establish a reliable, U.S.-produced supply of molybdenum-99 (Mo-99), the most commonly used medical isotope, without the use of highly enriched uranium.

read more

AIQ Solutions Hits On $3.2M to Pinpoint Drug-Resistant Tumors

Many companies developing artificial intelligence software for healthcare are trying to improve doctors’ ability to diagnose disease. Fewer emerging healthcare AI businesses are focused on what happens after a diagnosis, aiming to figure out how treatments are working.

read more

SHINE files application with NRC

July 22nd, 2019 – JANESVILLE, WI – SHINE Medical Technologies LLC today announced that the company has filed an application with the U.S. Nuclear Regulatory Commission to produce medical isotopes, including molybdenum-99 (Mo-99), iodine-131 and xenon-133, at its production facility in Janesville, WI. 

read more

Phoenix Completes Milestone Test With Unprecedented Neutron Output And Reliability

ANESVILLE, Wis., June 19, 2019 /PRNewswire/ — Phoenix, LLC, a Madison, WI nuclear technology company, and SHINE Medical Technologies, a Janesville, WI medical isotope production company, today announced completion of a 132-hour test of the high-flux Phoenix neutron generator that will drive SHINE’s medical isotope production system. This is a vital milestone in proving out the performance and reliability of Phoenix’s neutron generator technology and SHINE’s medical isotope production process.

read more

Technology Demonstration Validates Business Case

Phoenix Neutron Generator Completes Milestone Validating Output and Reliability June 19th, 2019 – Janesville, WI – SHINE Medical Technologies, a Janesville, WI medical isotope production company, announced the completion of an important milestone validating the SHINE...

read more

Production Facility Groundbreaking

Production Facility Groundbreaking May 9th, 2019 – Janesville, WI – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, broke ground today on their first...

read more

SHINE Licenses Lu-177 Separation Process

Novel Separation Method Accelerates SHINE’s Path to Market for Cancer Treatment Isotopes May 15th, 2019 – Prague, Czechia – SHINE Medical Technologies, Inc. (SHINE), a Wisconsin company dedicated to being the world leader in the safe, clean, affordable production of...

read more